BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

  October 29, 2025

   · 

  17 min read
• Press Releases

  AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025

  October 29, 2025

   · 

  12 min read
• Press Releases

  Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

  October 29, 2025

   · 

  5 min read
• Press Releases

  NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries

  October 29, 2025

   · 

  8 min read
• Press Releases

  FDA Grants Interchangeable Designation to Fresenius Kabi’s Biosimilars Conexxence® and Bomyntra® (denosumab-bnht)

  October 29, 2025

   · 

  4 min read
• Press Releases

  Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025

  October 29, 2025

   · 

  3 min read
• Press Releases

  CREATE Medicines Unveils All-RNA T-Cell Engineering Platform: RetroT Enables Site-Specific, Durable CAR integration In Vivo

  October 29, 2025

   · 

  3 min read
• Press Releases

  Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

  October 29, 2025

   · 

  1 min read